Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

The patients' symptoms and clinical status may be correlated with device diagnostics, such as evolution of average heart rates, heart rate variability, and daily activity. Repeated measurement of ...

Exposure to temperatures of 100°F (38°C) or higher may nearly triple the number of episodes of a form of irregular heart ...

Special Report: Medtech EBR has reported a milestone quarter underpinned by submission of the final module of its premarket ...

The introduction of the iMac was a critical turning point for Apple. Here is how the iconic desktop has evolved over two ...

This study aimed to evaluate the outcomes of CRT therapy in CS patients, focusing on implantable cardioverter defibrillator (ICD) therapies, heart failure (HF) hospitalizations and mortality. Methods: ...

The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have ...

Cardiac resynchronization therapy (CRT) is considered a beneficial and disease-modifying treatment in appropriately selected heart failure (HF) patients. It reduces morbidity and mortality, reverses ...

Thousands of Americans with heart trouble have small implanted defibrillators, to help regulate their heartbeat and keep ...

But new research finds that on extremely hot days, people with the devices face nearly triple the odds for a dangerous ...